Login / Signup

Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data.

Makito MiyakeNobutaka NishimuraTakuto ShimizuMikiko OhnishiMasaomi KuwadaYoshitaka ItamiTakeshi InoueKenta OhnishiYoshihiro MatsumotoTakanori YoshidaYoshihiro TatsumiMasatake ShinoharaShunta HoriYosuke MorizawaDaisuke GotohYasushi NakaiSatoshi AnaiKazumasa TorimotoKatsuya AokiTomomi FujiiNobumichi TanakaKiyohide Fujimoto
Published in: Cancer management and research (2022)
We demonstrated a significant improvement in prognosis after the advent of pembrolizumab for patients with aUC. ICIs should not be restricted based on patient characteristics.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • case report
  • advanced non small cell lung cancer
  • locally advanced
  • machine learning
  • liver metastases
  • replacement therapy
  • data analysis
  • artificial intelligence